|
Screening
|
Who needs it
|
How often
|
|
Alcohol misuse
|
All adults
|
At routine exams
|
|
Blood pressure
|
All adults
|
Every two years if your blood pressure reading is less than 120/80 mm Hg*
Yearly if your systolic blood pressure reading is 120 to 139 mm Hg or your diastolic blood pressure reading is 80 to 89 mm Hg*
|
|
Colorectal cancer
|
Men diagnosed with specific inherited syndromes and inflammatory bowel disease
|
Discuss with your health care provider to make an informed decision based on your family history, current medical condition, and personal values
|
|
Depression
|
All adults who have access to clinical practices with staff and systems in place to assure accurate diagnosis, effective treatment, and follow-up
|
At routine exams
|
|
Diabetes mellitus, type 2
|
Adults who are asymptomatic and have sustained blood pressure (treated or untreated) greater than 135/80 mm Hg
|
At routine exams
|
|
HIV
|
Anyone at increased risk for infection
|
At routine exams
|
|
Lipid disorders
|
All men age 35 and older, and younger men at high risk for coronary artery disease
|
At least every five years
|
|
Obesity
|
All adults
|
At routine exams
|
|
Syphilis
|
Anyone at increased risk for infection
|
At routine exams
|
|
Tuberculosis
|
Anyone at increased risk for infection
|
Check with your health care provider
|
|
Counseling
|
Who needs it
|
How often
|
|
Diet, behavioral counseling
|
Adults with hyperlipidemia and other known risk factors for cardiovascular and diet-related chronic disease
|
When diagnosed
|
|
Tobacco use and tobacco-related disease
|
All adults
|
Every visit
|
|
Immunization
|
Who needs it
|
How often
|
|
Tetanus/diphtheria/pertussis (Td/Tdap) booster
|
All adults
|
Td: Every 10 years
Tdap: Substitute a one-time dose of Tdap for a Td booster after age 18
|
|
Measles, mumps, rubella (MMR)
|
All adults ages 19 to 49 who lack evidence of immunity (no documentation of prior infection or vaccinations)**
|
One or two doses
|
|
Chickenpox (varicella)
|
All adults ages 19 to 49 who lack evidence of immunity (no documentation of prior infection or vaccinations)**
|
Two doses; the second dose should be given 4 to 8 weeks after the first dose
|
|
Flu (seasonal)
|
People at risk**
|
Yearly during flu season
|
|
Hepatitis A
|
People at risk**
|
Two doses: For Havrix, at zero and 6 to 12 months; or for Vaqta, at zero and 6 to 18 months
|
|
Hepatitis B
|
People at risk**
|
Three doses over six months
|
|
Human papillomavirus (HPV4)
|
Men ages 19 to 26
|
Three doses; the second dose should be given 1 to 2 months after the first dose and the third dose given 6 months after the first dose
|
|
Meningococcal
|
People at risk**
|
One or more doses
|
|
Pneumococcal (polysaccharide)
|
People at risk**
|
One or more doses
|